EGF and non-small cell lung carcinoma: Based on the findings reported in the literature [10, 11], we hypothesized that dysregulation of Copine 1 via the EGF signaling pathway and knockdown of CPNE1 expression could sensitize NSCLC cells to therapeutic agents.